OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
10/10/2025
Voltar para busca
Dado oficial do USPTO
NEC
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
30
Atualização mais recente
11/10/2025
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
5, 9, 35, 42, 44
Data de depósito
08/11/2023
Data de registro
28/01/2025
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
28/01/2025
Última transação
11/10/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
5
Tipo de titular
03
Localização do titular
JP
Examinador
GUARNIERI,GRACE K
Localização atual
FILE REPOSITORY (FRANCONIA)
Descrição da marca
The mark consists of the letters "NEC" in stylized block text.
Titulares e representantes
Titulares
Nippon Denki Kabushiki Kaisha (NEC Corporation)
Representantes
Richard Y. Kim Snell & Wilmer L.L.P.
Classificação técnica
Classes Nice
Classe 5Classe 9Classe 35Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Vaccines; vaccines preparations; vaccine preparations for the prevention and treatment of cancerinfection and auto immune disease; pharmaceuticals and pharmaceutical preparations for human use for the prevention and treatment of cancerinfection and auto immune disease; companion diagnostic agents for medical use; pharmaceutical preparations for the treatment and prevention of cancerinfection and auto immune disease namely cellular therapeutics; pharmaceutical preparations for the treatment of cell related viral diseases; reagent paper for medical purposes; dietary supplements for humans; dietetic beverages adapted for medical purposes; dietetic foods adapted for medical purposes; dietetic beverages adapted for medical purposesdrinks for babies; food for babies; dietary supplements for animals
Classe 9
Downloadable and recorded computer software for use in analyzing and identifying genome information; Downloadable and recorded computer software for medical process management of individual personalized treatment; Downloadable and recorded computer software for patient stratification; Downloadable and recorded operating system computer software for use with companion diagnostic medical devices; Downloadable and recorded computer software platforms for use in medical data management; Downloadable and recorded computer operating programs; Downloadable and recorded computer operating system software; computers and computer hardware; computer network servers; computer peripheral apparatus; Downloadable and recorded computer software and downloadable application software for collecting and storage of patient data and medical information; Data processing equipment in the nature of data processing systems for collecting and storage of patient data and medical information
Classe 35
Collection of information into computer databases in the field of genetic and genomic information and life science; Collection of genome information into computer databases for medical purposes; collection of information into computer databases in the field of medical information
Classe 42
Research and development of vaccines and medicines; scientific research in the nature of conducting clinical trials for others; research and development of medicines in the nature of companion diagnostic agent; testinginspection or research of pharmaceuticalscosmetics or foodstuffs; scientific research in the field of genetics; medical research; design and development of computer hardware and software for use in companion diagnostic; designing of machinesapparatusinstruments and their parts or systems composed of such machinesapparatus and instruments; technology advisory and consultancy services relating to the design and development of computer hardware; computer programming; medical and scientific research in the field of gene analysis; Scientific and technological servicesgenome researchtestinganalysisevaluation of genome samples for scientific research purposes and providing information thereof; Scientific and technological servicesinvestigation and analysis of genome samples for scientific research purposes; providing on-line non downloadable software for use in analyzing and identifying genome information; providing on-line non downloadable software for medical process management of individual personalized treatment; providing on-line non downloadable software for patient stratification; providing on-line non downloadable operating system software for use with companion diagnostic medical devices; platform as a service (PaaS) featuring computer software platforms for use in medical data management; design and development of computer software for medical data analysis and management; rental of computers; providing temporary use of on-line non- downloadable cloud computing software and computer programs on data networks for medical data management; software as a service (SaaS) featuring software for medical data management; research and development in the field of cellular therapeutics; structural and functional analysis of genomes; Providing information about medical researchgenome information analysis; Scientific and technological servicesproviding scientific analysis in the field of genomic data; providing on-line non downloadable software for use in collectinganalyzingevaluatinginterpreting and predicting genetic and genomic information; providing science information in the fields of genetic and genomic information and life science; Biological research in the nature of analysis of biological samples
Classe 44
Providing medical information related to the preservation of genome information for medical purposes; Providing medical information in the nature of collected genome information; providing medical information in the field of cellular therapeutics; medical diagnostic testing and monitoring services in the field of cellular therapeuticscell therapy; medical assistance services in the nature of information about genetic testing and medical information provided to remote medical professionals via the Internet and global computer networks through the use of genome sequence informationmedical imagesdiagnostic test resultsdata storage and retrieval systems; medical services relating to the collectionprocessing and preservation of biological samples; collection and preservation of biological sampleshuman cells; medical laboratory services for the analysis of biological samples; medical analysis services for diagnostic and treatment provided by medical laboratories relating to celltissuegene expressiongene sequencegenome annotationtranscriptome characteristic analysisgenome mapping; provision of medical information; physical examination services; providing an internet website for medical professionals and medical patients featuring medical information and medical data which users processexchange and access in real time
Publicações
Histórico de despachos e eventos da marca no USPTO.
30 publicações encontradas
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
24/09/2025
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
24/09/2025
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
05/09/2025
FICS
FINAL DISPOSITION NOTICE SENT TO IB
16/08/2025
FIMP
FINAL DISPOSITION PROCESSED
16/08/2025
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
29/04/2025
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
28/01/2025
R.PR
REGISTERED-PRINCIPAL REGISTER
28/01/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10/12/2024
PUBO
PUBLISHED FOR OPPOSITION
10/12/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/12/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
14/11/2024
XAEC
EXAMINER'S AMENDMENT ENTERED
08/11/2024
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
08/11/2024
GNEA
EXAMINERS AMENDMENT E-MAILED
08/11/2024
CNEA
EXAMINERS AMENDMENT -WRITTEN
08/11/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
16/10/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
16/10/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
16/10/2024
RFNT
REFUSAL PROCESSED BY IB
11/08/2024
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
23/07/2024
RFRR
REFUSAL PROCESSED BY MPU
23/07/2024
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
27/06/2024
CNRT
NON-FINAL ACTION WRITTEN
26/06/2024
DOCK
ASSIGNED TO EXAMINER
17/06/2024
MAFR
APPLICATION FILING RECEIPT MAILED
10/05/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/05/2024
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
02/05/2024
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
25/04/2024
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace NEC ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.